Antiangiogenic Agents for Cancer May Boost Aneurysm Risk
NEW YORK (Reuters Health) – Caution may be required when using anticancer drugs targeting angiogenesis because of the potential risk […]
» Read moreHome »
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with […]
HER2+ early breast cancers where shorter-course trastuzumab could be an option
